Drugs Made In America Acquisition Corp
DMAA10.440USD
-0.010-0.10%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
349.92M시가총액
95.17P/E TTM
자세한 내용은 Drugs Made In America Acquisition Corp 회사
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp 정보
종목 코드 DMAA
회사 이름Drugs Made In America Acquisition Corp
상장일Jan 28, 2025
CEOStockwell (Lynn)
직원 수- -
유형Ordinary Share
회계 연도 종료Jan 28
주소1 East Broward Boulevard
도시FT LAUDERDALE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33301
전화19548703099
웹사이트
종목 코드 DMAA
상장일Jan 28, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
기타
49.03%
주주
주주
비율
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
기타
49.03%
주주 유형
주주
비율
Hedge Fund
30.42%
Corporation
25.57%
Investment Advisor/Hedge Fund
24.61%
Investment Advisor
5.80%
Research Firm
5.62%
Individual Investor
1.19%
기타
6.79%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
47
22.21M
67.76%
-8.45K
2025Q3
47
22.22M
67.76%
+1.02M
2025Q2
38
21.21M
54.90%
+2.81M
2025Q1
25
18.33M
0.00%
+18.33M
2024Q4
5
4.59M
15.73%
+4.59M
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Drugs Made In America Acquisition LLC
8.57M
25.57%
+4.38M
+104.63%
Feb 25, 2025
Karpus Investment Management
2.55M
7.6%
-196.44K
-7.16%
Sep 30, 2025
First Trust Capital Management L.P.
2.24M
6.69%
--
--
Sep 30, 2025
Polar Asset Management Partners Inc.
1.90M
5.67%
--
--
Sep 30, 2025
Glazer Capital, LLC
1.82M
5.44%
-158.00
-0.01%
Sep 30, 2025
Westchester Capital Management, LLC
1.67M
4.98%
--
--
Sep 30, 2025
Hudson Bay Capital Management LP
1.55M
4.62%
-250.00K
-13.89%
Sep 30, 2025
Wolverine Asset Management, LLC
1.25M
3.73%
+227.22K
+22.24%
Sep 30, 2025
Mizuho Securities USA, LLC.
1.10M
3.28%
+180.66K
+19.64%
Sep 30, 2025
Aristeia Capital, L.L.C.
881.72K
2.63%
--
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
CrossingBridge Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
